Literature DB >> 32485324

Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers.

Veena Shankaran1, Joseph M Unger2, Amy K Darke2, Dawn L Hershman3, Scott D Ramsey4.   

Abstract

BACKGROUND: Few studies have assessed the financial impact of cancer diagnosis on patients and caregivers in diverse clinical settings. S1417CD, led by the SWOG Cancer Research Network, is the first prospective longitudinal cohort study assessing financial outcomes conducted in the NCI Community Oncology Research Program (NCORP). We report our experience navigating design and implementation barriers.
METHODS: Patients age ≥ 18 within 120 days of metastatic colorectal cancer diagnosis were considered eligible and invited to identify a caregiver to participate in an optional substudy. Measures include 1) patient and caregiver surveys assessing financial status, caregiver burden, and quality of life and 2) patient credit reports obtained from the credit agency TransUnion through a linkage requiring social security numbers and secure data transfer processes. The primary endpoint is incidence of treatment-related financial hardship, defined as one or more of the following: debt accrual, selling or refinancing home, ≥20% income decline, or borrowing money. Accrual goal was n = 374 patients in 3 years.
RESULTS: S1417CD activated on Apr 1, 2016 and closed on Feb 1, 2019 after reaching its accrual goal sooner than anticipated. A total of 380 patients (median age 59.7 years) and 155 caregivers enrolled across 548 clinical sites. Credit data were not obtainable for 76 (20%) patients due to early death, lack of credit, or inability to match records.
CONCLUSIONS: Robust accrual to S1417CD demonstrates patients' and caregivers' willingness to improve understanding of financial toxicity despite perceived barriers such as embarrassment and fears that disclosing financial status could influence treatment recommendations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical oncology; Healthcare disparities; Healthcare economics and organizations

Year:  2020        PMID: 32485324      PMCID: PMC8171354          DOI: 10.1016/j.cct.2020.106037

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  28 in total

1.  ABMT and breast cancer: what have we learned?

Authors:  E Brown
Journal:  Physician Exec       Date:  1999 Jul-Aug

2.  THE OREGON HEALTH INSURANCE EXPERIMENT: EVIDENCE FROM THE FIRST YEAR.

Authors:  Amy Finkelstein; Sarah Taubman; Bill Wright; Mira Bernstein; Jonathan Gruber; Joseph P Newhouse; Heidi Allen; Katherine Baicker
Journal:  Q J Econ       Date:  2012-05-03

3.  Time costs associated with informal caregiving for cancer survivors.

Authors:  K Robin Yabroff; Youngmee Kim
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

4.  For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships.

Authors:  Matthew P Banegas; Gery P Guy; Janet S de Moor; Donatus U Ekwueme; Katherine S Virgo; Erin E Kent; Stephanie Nutt; Zhiyuan Zheng; Ruth Rechis; K Robin Yabroff
Journal:  Health Aff (Millwood)       Date:  2016-01       Impact factor: 6.301

5.  Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors.

Authors:  K Robin Yabroff; Emily C Dowling; Gery P Guy; Matthew P Banegas; Amy Davidoff; Xuesong Han; Katherine S Virgo; Timothy S McNeel; Neetu Chawla; Danielle Blanch-Hartigan; Erin E Kent; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Zhiyuan Zheng; Ahmedin Jemal; Donatus U Ekwueme
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

6.  American Society of Clinical Oncology guidance statement: the cost of cancer care.

Authors:  Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

7.  Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

Authors:  Bruce J Giantonio; Paul J Catalano; Neal J Meropol; Peter J O'Dwyer; Edith P Mitchell; Steven R Alberts; Michael A Schwartz; Al B Benson
Journal:  J Clin Oncol       Date:  2007-04-20       Impact factor: 44.544

8.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Authors:  Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

9.  The financial impact of head and neck cancer caregiving: a qualitative study.

Authors:  Myles Balfe; Phyllis Butow; Eleanor O'Sullivan; Rachael Gooberman-Hill; Aileen Timmons; Linda Sharp
Journal:  Psychooncology       Date:  2016-01-26       Impact factor: 3.894

10.  Understanding patients' attitudes toward communication about the cost of cancer care.

Authors:  Andrea J Bullock; Erin W Hofstatter; Melinda L Yushak; Mary K Buss
Journal:  J Oncol Pract       Date:  2012-02-28       Impact factor: 3.840

View more
  1 in total

1.  S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.

Authors:  Veena Shankaran; Joseph M Unger; Amy K Darke; Jennifer Marie Suga; James L Wade; Peter J Kourlas; Sreenivasa R Chandana; Mark A O'Rourke; Suma Satti; Diane Liggett; Dawn L Hershman; Scott D Ramsey
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.